Aug 11, 2020 / 08:30PM GMT
Operator
Good afternoon, ladies and gentlemen, and thank you for joining the Alpine Immune Sciences second-quarter 2020 financial results and corporate update conference call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session. (Operator Instructions) As a reminder, this conference is being recorded today, Tuesday, August 11, 2020.
I would now like to introduce Laurence Watts, Investor Relations. Please, go ahead.
Laurence Watts - Gilmartin Group LLC - IR
Thank you, Sydney. With me on today's call from Alpine Immune Sciences, are Executive Chairman and CEO, Dr. Mitchell Gold; President and Head of Research and Development, Dr. Stanford Peng; Chief Financial Officer, Paul Rickey; and Senior Vice President of Business Development and Corporate Strategy, Remy Durand.
[This afternoon] Alpine Immune Sciences issued a press release announcing the company's second-quarter 2020 financial results and corporate update. If you have not received this news release and would like to read it
Q2 2020 Alpine Immune Sciences Inc Earnings Call Transcript
Aug 12, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers